Patents by Inventor Sanjeet Singh Sehmi

Sanjeet Singh Sehmi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzazepine derivatives for the treatment of neurological disorders
    Patent number: 8207331
    Abstract: The present invention relates to novel benzazepine derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.
    Type: Grant
    Filed: February 17, 2010
    Date of Patent: June 26, 2012
    Assignee: Glaxo Group Limited
    Inventors: Mark James Bamford, David Kenneth Dean, Sanjeet Singh Sehmi, David Matthew Wilson, Jason Witherington
  • Benzazepine derivatives for the treatment of neurological disorders
    Patent number: 7799773
    Abstract: The present invention relates to novel benzazepine derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.
    Type: Grant
    Filed: December 19, 2008
    Date of Patent: September 21, 2010
    Assignee: Glaxo Group Limited
    Inventors: Mark James Bamford, David Kenneth Dean, Sanjeet Singh Sehmi, David Matthew Wilson, Jason Witherington
  • Benzazepine Derivatives For The Treatment of Neurological Disorders
    Publication number: 20100145040
    Abstract: The present invention relates to novel benzazepine derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.
    Type: Application
    Filed: February 17, 2010
    Publication date: June 10, 2010
    Inventors: Mark James Bamford, David Kenneth Dean, Sanjeet Singh Sehmi, David Matthew Wilson, Jason Witherington
  • Benzazepine derivatives for the treatment of neurological disorders
    Patent number: 7704994
    Abstract: The present invention relates to benzazepine derivatives of formula (I) wherein: R1 represents —C3-7 cycloalkyl optionally substituted by C1-3 alkyl; having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.
    Type: Grant
    Filed: July 31, 2007
    Date of Patent: April 27, 2010
    Assignee: Glaxo Group Limited
    Inventors: Sanjeet Singh Sehmi, David Matthew Wilson, Jason Witherington
  • Benzazepine derivatives for the treatment of neurological disorders
    Patent number: 7696193
    Abstract: The present invention relates to benzazepine derivatives of formula (I) wherein: R1 represents —C3-7 cycloalkyl optionally substituted by C1-3 alkyl; having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.
    Type: Grant
    Filed: December 18, 2003
    Date of Patent: April 13, 2010
    Assignee: Glaxo Group Limited
    Inventors: Sanjeet Singh Sehmi, David Matthew Wilson, Jason Witherington
  • BENZAZEPINE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
    Publication number: 20090105226
    Abstract: The present invention relates to novel benzazepine derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.
    Type: Application
    Filed: December 19, 2008
    Publication date: April 23, 2009
    Inventors: Mark James BAMFORD, David Kenneth Dean, Sanjeet Singh Sehmi, David Matthew Wilson, Jason Witherington